Age : 55
Gender : Male
Nationality : Malaysian
Date of Appointment to Present
Position : 1 January 2023 Working Experience Dr. Badarulhisam is the Chief Scientific Officer of Pharmaniaga Berhad. He spearheads product development and regulatory strategies for the Company, which include product ideation, development, trial, registration, and product life cycle management. He has extensive experience in pharmaceutical and biopharmaceutical manufacturing plant design, construction, equipment and facility qualification & validation and the operation of these plants for the manufacturing of various therapeutic segments and dosage forms including vaccine.
He was also instrumental in establishing Pharmaniaga’s Group-wide sustainability programme, which he headed from 2017 to 2022. He is a qualified Biochemical Engineer with expertise in Biochemical Engineering and Biotechnology.
He completed his Advanced Diploma and Master of Science at University College of London in the United Kingdom. Subsequently, he obtained his PhD from Johns Hopkins University in the United States of America.
Dr. Badarulhisam began his career as a lecturer at the Department of Bioprocess Engineering, Universiti Teknologi Malaysia, where he is still academically active. He then served as an Adjunct Professor at the Chemical Engineering Department of Universiti Putra Malaysia.
Amongst his other accomplishments include his appointment as Board ofAcademic Advisory of the Faculty of Engineering at Universiti Kebangsaan Malaysia and several other universities. He has also served as an industrial advisor to several Bioprocess Engineering Programmes of major universities in Malaysia and co-supervises masters and PhD students in various aspects of Biopharmaceutical Plant Design, Biologics Drug Development and Process Optimisations. Qualification(s):
• PhD in Biotechnology, Johns Hopkins University • MSc in Biochemical Engineering, University College London, United Kingdom • Advanced Diploma in Biochemical Engineering, University College London, United Kingdom
Any directorship in public companies and
public listed companies:
• None
Directorship in public companies:
• None.
Any family relationship with any director
and/major shareholder of the Company:
• None
Any conflict of interests with the Company:
• None.
Other than traffic offences, any convictions
for offences within the past 5 years and
other particulars of any public sanction or
penalty imposed by the relevant regulatory
bodies during the financial year, if any:
• None